CARECLOUD Stock Price, News & Analysis

CareCloud, Inc. 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (Nasdaq: CCLDO) represents a preferred equity security issued by CareCloud, Inc., a healthcare technology company listed on Nasdaq under the symbols CCLD and CCLDO. CareCloud focuses on AI-powered and technology-enabled solutions that support medical practices, hospitals, integrated health systems, and healthcare providers across the United States.

According to multiple company disclosures, CareCloud describes its approach as bringing disciplined innovation to the business of healthcare. Its solutions are designed to help clients increase financial and operational performance, streamline clinical workflows, and improve the patient experience. The company reports that tens of thousands of providers rely on its platform to improve patient care while reducing administrative burdens and operating costs.

CareCloud’s Healthcare Technology Platform

CareCloud identifies itself as a healthcare technology and AI-driven solutions provider. Across its press releases and corporate descriptions, the company highlights a suite of offerings that includes:

• Revenue Cycle Management (RCM) solutions, focused on billing and financial performance in healthcare organizations.
• Practice Management (PM) tools to support administrative and operational workflows in medical practices.
• Electronic Health Records (EHR) systems used to document and manage clinical information.
• Business Intelligence (BI) and analytics capabilities that provide insights into financial and operational metrics.
• Patient Experience Management (PXM) solutions aimed at improving patient engagement and satisfaction.
• Digital health offerings that extend CareCloud’s technology footprint across care settings.
• Artificial intelligence (AI) and generative AI capabilities that the company integrates into workflows such as revenue cycle, analytics, and patient access.

CareCloud also notes that it operates an AI Center of Excellence, which is tasked with driving AI-driven product innovation across inpatient and ambulatory EHR, RCM, analytics, and patient engagement. The company has reported acquisitions, including Medsphere’s hospital IT business and HFMA’s MAP App, to expand its reach in hospital and integrated health system markets and to enhance AI-driven benchmarking and revenue cycle tools.

Role of the CCLDO Series B Preferred Stock

The 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, trading under the ticker CCLDO on the Nasdaq Global Market, is a preferred equity security with specific dividend and redemption features described by the company in its dividend and capital markets communications.

CareCloud states that holders of the Series B Preferred Stock are entitled to cumulative cash dividends at the rate of 8.75% per annum of the $25.00 per share liquidation preference, which the company equates to $2.1875 per annum per share. Dividends are described as cumulative and payable monthly, generally on or about the 15th day of each month, to holders of record as of the last day of the preceding calendar month, subject to business day conventions.

The company has communicated that dividends on the Series B Preferred Stock can accumulate if not paid, and it has discussed periods of accumulated and unpaid dividends, as well as plans to address those arrears. For example, CareCloud announced a formal plan to satisfy accumulated dividends on the Series B Preferred Stock by issuing double monthly dividend payments—one regular monthly dividend plus an additional payment related to dividends in arrears—until past due dividends are fully satisfied. The company linked this plan to what it described as a successful turnaround, enhanced margins, and growing recurring revenues and cash flow.

Redemption Features of CCLDO

CareCloud has outlined redemption terms for the Series B Preferred Stock. The company states that it may, at its option and upon not less than 30 nor more than 60 days’ written notice, redeem the Series B Preferred Stock, in whole or in part, at specified cash redemption prices per share, plus any accumulated and unpaid dividends to, but not including, the redemption date.

The redemption prices disclosed by the company for the Series B Preferred Stock are:

• $25.50 per share for redemptions on and after a stated date in 2025 and prior to a stated date in 2026.
• $25.25 per share for redemptions on and after a stated date in 2026 and prior to a stated date in 2027.
• $25.00 per share for redemptions on and after a stated date in 2027.

CareCloud also notes that, upon the occurrence of a Change of Control (as defined in the applicable governing documents), it may, at its option and upon similar notice, redeem the Series B Preferred Stock, in whole or in part, within a specified period after the first date on which such Change of Control occurred, at a redemption price of $25.00 per share plus any accumulated and unpaid dividends to, but not including, the redemption date.

CareCloud’s AI and Product Expansion

Beyond the preferred stock terms, CareCloud’s recent announcements provide context on the business underlying CCLDO. The company has emphasized its AI-driven strategy, including:

• The launch of stratusAI Desk Agent, described as an agentic AI phone receptionist that automates and modernizes patient phone interactions, manages high call volumes, and integrates with EHR and PM systems to handle tasks such as appointment scheduling, call triage, prescription refill requests, referral intake, responses to common questions, and pre-visit instructions.
• The introduction of stratusAI Voice Audit, characterized as a conversational intelligence platform that, when combined with stratusAI Desk Agent, provides call monitoring, quality scoring, analytics on call volumes and service levels, AI-driven performance metrics, and insights into patient sentiment and unmet needs.
• The acquisition of Medsphere’s hospital IT business, which added hospital-focused software capabilities and expanded CareCloud’s reach into inpatient settings.
• The acquisition of HFMA’s MAP App, a hospital benchmarking tool used to measure revenue cycle management performance, with plans to expand its capabilities using AI and to grow its adoption among hospitals and integrated health systems.
• The addition of Wellsoft, an emergency department information system (EDIS) acquired through Medsphere, which CareCloud has positioned as an emergency-grade documentation platform now being introduced into the urgent care market.

In its descriptions, CareCloud highlights that these AI and software offerings are intended to support both ambulatory and hospital markets, spanning clinical documentation, revenue cycle, analytics, and patient access workflows.

CareCloud’s Market Focus

CareCloud’s communications repeatedly emphasize its focus on medical practices, health systems, hospitals, and urgent care organizations across the United States. The company describes its client base in terms of providers who rely on its technology to manage clinical workflows, financial performance, and patient engagement. CareCloud notes that urgent care has become a major access point in outpatient care and has highlighted the deployment of its Wellsoft platform in urgent care settings as an extension of its emergency department capabilities.

In addition, CareCloud has referenced its presence in both ambulatory and inpatient software markets, supported by acquisitions and AI initiatives. The company has also discussed presenting at investor conferences and being included in an index that focuses on smaller-capitalization companies, which provides additional context for investors evaluating CCLDO as a preferred equity linked to a healthcare technology and AI platform.

Series B Preferred Dividends and Arrears

CareCloud has disclosed that dividends on the Series B Preferred Stock are cumulative and that, during a specified period, dividends accumulated and were unpaid. The company has described an arrears balance associated with 14 months of accumulated dividends on the Series B Preferred Stock and has outlined a plan to address these arrears through additional payments layered on top of regular monthly dividends.

CareCloud has also communicated that current monthly dividends on the Series B Preferred Stock were reinstated and that it has been paying preferred stock dividends from internally generated free cash flow. The company notes that dividends are subject to the terms of the applicable Certificate of Designations, Preferences and Rights, and that it reserves the right to adjust the timing of dividend payments, including catch-up payments, in the event of unforeseen circumstances, consistent with those governing documents.

Positioning of CCLDO for Investors

For investors researching CCLDO, the security represents an 8.75% cumulative redeemable perpetual preferred stock tied to CareCloud’s healthcare technology and AI business. The company’s disclosures provide detail on dividend rates, payment schedules, redemption options, and the cumulative nature of the security. At the same time, CareCloud’s broader business activities—such as AI-enabled revenue cycle solutions, EHR and practice management platforms, hospital IT acquisitions, and AI-driven patient access tools—form the operating backdrop for this preferred stock.

Because CCLDO is a preferred equity instrument, its characteristics differ from CareCloud’s common stock (CCLD), particularly in terms of dividend priority, redemption features, and liquidation preference. Investors typically review the company’s official offering documents and certificates of designations for full legal terms, while company press releases and financial reports provide ongoing context about dividend practices, arrears plans, and the underlying business performance.